Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From latent to patent: rethinking prediction of tuberculosis.
Cobelens F, Kik S, Esmail H, Cirillo DM, Lienhardt C, Matteelli A. Cobelens F, et al. Among authors: esmail h. Lancet Respir Med. 2017 Apr;5(4):243-244. doi: 10.1016/S2213-2600(16)30419-2. Epub 2016 Dec 22. Lancet Respir Med. 2017. PMID: 28017341 No abstract available.
Detection and treatment of subclinical tuberculosis.
Robertson BD, Altmann D, Barry C, Bishai B, Cole S, Dick T, Duncan K, Dye C, Ehrt S, Esmail H, Flynn J, Hafner R, Handley G, Hanekom W, van Helden P, Kaplan G, Kaufmann SH, Kim P, Lienhardt C, Mizrahi V, Rubin E, Schnappinger D, Sherman D, Thole J, Vandal O, Walzl G, Warner D, Wilkinson R, Young D. Robertson BD, et al. Among authors: esmail h. Tuberculosis (Edinb). 2012 Nov;92(6):447-52. doi: 10.1016/j.tube.2012.06.004. Epub 2012 Jul 21. Tuberculosis (Edinb). 2012. PMID: 22819716 Free article.
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.
Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, Dièye S, Dieye TN, Esmail H, Goliath R, Huygen K, January V, Ndiaye I, Oni T, Raine M, Romano M, Satti I, Sutton S, Thiam A, Wilkinson KA, Mboup S, Wilkinson RJ, McShane H; MVA85A 030 trial investigators. Ndiaye BP, et al. Among authors: esmail h. Lancet Respir Med. 2015 Mar;3(3):190-200. doi: 10.1016/S2213-2600(15)00037-5. Epub 2015 Feb 26. Lancet Respir Med. 2015. PMID: 25726088 Free PMC article. Clinical Trial.
Spotting the old foe-revisiting the case definition for TB.
Houben RMGJ, Esmail H, Emery JC, Joslyn LR, McQuaid CF, Menzies NA, Sanz J, Shrestha S, White RG, Yang C, Cobelens F. Houben RMGJ, et al. Among authors: esmail h. Lancet Respir Med. 2019 Mar;7(3):199-201. doi: 10.1016/S2213-2600(19)30038-4. Lancet Respir Med. 2019. PMID: 30823971 No abstract available.
Screening for tuberculosis: time to move beyond symptoms.
Yoon C, Dowdy DW, Esmail H, MacPherson P, Schumacher SG. Yoon C, et al. Among authors: esmail h. Lancet Respir Med. 2019 Mar;7(3):202-204. doi: 10.1016/S2213-2600(19)30039-6. Lancet Respir Med. 2019. PMID: 30823972 Free PMC article. No abstract available.
Individualising therapy for drug-sensitive tuberculosis.
Esmail H, Lipman MC, Nunn A, Walker TM. Esmail H, et al. Lancet Respir Med. 2019 Oct;7(10):834-835. doi: 10.1016/S2213-2600(19)30247-4. Epub 2019 Aug 16. Lancet Respir Med. 2019. PMID: 31427253 No abstract available.
73 results